RiverVest
Venture Capital
Active
St. Louis, United States
89
43M
51
3.71
13
0.43
20
- Stages of investment
- Areas of investment
Summary
RiverVest is the famous VC, which was founded in 2000. The venture was found in North America in United States. The main department of described VC is located in the St Louis.
The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Manufacturing. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ZS Pharma, Arch Oncology, OncoResponse.
The fund was created by Jay W. Schmelter. The overall number of key employees were 6.
Opposing the other organizations, this RiverVest works on 3 percentage points less the average amount of lead investments. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2011. Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the RiverVest, startups are often financed by Cultivation Capital, Alta Partners, PTV Healthcare Capital. The meaningful sponsors for the fund in investment in the same round are Alta Partners, Arnerich Massena & Associates, 3x5 Special Opportunity Fund. In the next rounds fund is usually obtained by 3x5 Special Opportunity Fund, Alta Partners, Arnerich Massena & Associates.
Investor highlights
- Industry focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 275000000
- Fund raised date
- 2021-03-23
Analytics
- Total investments
- 89
- Lead investments
- 13
- Exits
- 20
- Rounds per year
- 3.71
- Follow on index
- 0.43
- Investments by industry
- Biotechnology (65)
- Health Care (51)
- Medical (30)
- Therapeutics (25)
- Pharmaceutical (25) Show 17 more
- Investments by region
-
- United States (84)
- Germany (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 31M
- Group Appearance index
- 0.98
- Avg. company exit year
- 8
- Avg. multiplicator
- 1.65
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bluejay Therapeutics | 09 May 2024 | Biotechnology, Health Care | Late Stage Venture | 182M | |
| Standard Bariatrics | 01 Jun 2021 | Health Care, Medical Device, Medical | Early Stage Venture | 35M | United States, Ohio, Cincinnati |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.